Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
Today’s news reports address: Daily fat intake and risk for prostate cancer Salvage RALP as a treatment for patients in biochemical relapse after first-line EBRT Phase II data on fenretinide as a possible treatment for HRPC
Filed under: Drugs in development, Management, Prevention, Risk, Treatment | Tagged: fat intake, fatty acids, fenretinide, MUFA, PUFA, RALP, robot-assisted laparoscopic prostatectomy, salvage, SFA | Leave a Comment »
A newly published report suggests that sexual function does indeed decline after external beam radiation therapy (EBRT) for prostate cancer — but only over the first 2 years post-treatment.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: EBRT, ED, erectile dysfucntion, external beam radiation therapy, sexual function | 2 Comments »
Search for new and
ongoing trials on the
CTAG PCa web site